Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Hankerchiefon Oct 01, 2020 9:06am

80 Views

Post# 31647819

RE:RE:Theralase Announces Warrant Extension

enriquesuave wrote: I guessed right this week. Like I said that means No dilution like some were calling. It's obvious they have enough cash to get us thru to next data point and or other significant news, at which point extra cash will come from excercised of 30 and 50 cent warrants and no need for further dilution. Should have enough cash for all of PH2 and 1 or 2 PH1 trials. All IMo

Wouldn't the share price have to be over 30 and 50 cents in order to stimulate exercising the warrants? Who would exercise them at 15 cents?

Bullboard Posts

Soma Gold poised to extend profitable track record